Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma

Journal of Drug Targeting

Volumn 16, Issue 10, 2008, Pages 725-732

  Li, Qi ^a   Wang, Yan ^a   Feng, Nianping ^a   Fan, Zhongze ^a   Sun, Jue ^a   Nan, Yilei ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Hepatoma; Nanoparticles; PLA; Tanshinone IIA; Therapy

Indexed keywords

NANOCARRIER; SOLVENT; TANSHINONE; TANSHINONE IIA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER INHIBITION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; EMULSION; EVAPORATION; HEART; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PARENCHYMA; LIVER CELL CARCINOMA; LUNG PARENCHYMA; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPLEEN; SURVIVAL TIME; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; MICE; NANOPARTICLES; PHENANTHRENES; POLYMERS; TISSUE DISTRIBUTION;

EID: 56349115456     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860802374303     Document Type: Article

References (25)

1. Bi, X., Shi, X. and Baker Jr, JR (2008) Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate. J Biomater Sci Polym Ed, 19:1, pp. 131-142.
2. Chawla, JS and Amiji, MM (2002) Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm, 249:1, pp. 127-138.
3. Chen, JL, Chiang, CH and Yeh, MK (2002) The mechanism of PLA microparticle formation by water-in-oil-in-water solvent evaporation method. J Microencapsul, 19:3, pp. 333-346.
4. Damge, C., Reis, CP and Maincent, P. (2008) Nanoparticle strategies for the oral delivery of insulin. Expert Opin Drug Deliv, 5:1, pp. 45-68.
5. Garlich, JR, De PDey, N., Su, JD, Peng, X., Miller, A., Murali, R., Lu, Y., Mills, GB, Kundra, V., Shu, HK, Peng, Q., Durden, DL, Kato, T., Nemoto, R., Mori, H., Takahashi, M. and Tamakawa, Y. (1981) Transcatheter arterial chemoembolization of renal cell carcinoma with microencapsulated mitomycin C. J Urol, 125:1, pp. 19-24.
6. Gutierrez-Pauls, L., Gonzalez-Alvarez, I., Lareo Barone, M, Gil-Alegre, ME and Torres-Suarez, AI (2007) Poly(epsilon-caprolactone) microparticles formed by the emulsion-evaporation method: Effect of the variables of the different steps of the process on their size. Pharmazie, 62:11, pp. 864-868.
7. Helle, A., Hirsjarvi, S., Peltonen, L., Hirvonen, J. and Wiedmer, SK (2008) Quantitative determination of drug encapsulation in poly(lactic acid) nanoparticles by capillary electrophoresis. J Chromatogr A, 1178:1, pp. 621-630.
8. Hirsjarvi, S., Peltonen, L. and Hirvonen, J. (2008) Surface pressure measurements in particle interaction and stability studies of poly(lactic acid) nanoparticles. Int J Pharm, 348:1, pp. 153-160.
9. Huang, GQ, Song, Y., Zhang, J., Lu, YR, Xiao, L., Yang, Y. and Guo, YB (2004) Enhancement of the bystander effect by tanshinone IIA in HSV-tK/ GCV system is related to expression of connexin 43 mRNA. Zhonghua Zhong Liu Za Zhi, 26:3, pp. 146-149.
10. Lai, SK, Hida, K., Chen, C. and Hanes, J. (2008) Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles. J Control Release, 125:2, pp. 107-111.
11. Lee, AL, Wang, Y., Ye, WH, Yoon, HS, Chan, SY and Yang, YY (2008) Efficient intracellular delivery of functional proteins using cationic polymer core/shell nanoparticles. Biomaterials, 29:9, pp. 1224-1232.
12. 1 expression of hepatoma in mouse. Tumor, 28:1, pp. 8-12.
13. Liu, JJ, Lin, DJ, Liu, PQ, Huang, M., Li, XD and Huang, RW (2006) Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci, 13:6, pp. 813-823.
14. Liu, H., Slamovich, EB and Webster, TJ (2006) Less harmful acidic degradation of poly(lacticco-glycolic acid) bone tissue engineering scaffolds through titania nanoparticle addition. Int J Nanomed, 1:4, pp. 541-545.
15. Meade, VM, Burton, MA, Gray, BN and Self, GW (1987) Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncol, 23:1, pp. 37-41.
16. Mohamed, F. and van der Walle, CF (2008) Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci, 97:1, pp. 71-87.
17. Ogawa, Y., Yamamoto, M., Okada, H., Yashiki, T. and Shimamoto, T. (1988) A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic glycolic) acid. Chem Pharm Bull, 36:3, pp. 1095-1103.
18. Schwarz, A., Zhang, H., Metcalfe, A., Salazkin, I. and Raymond, J. (2004) Transcatheter embolization using degradable crosslinked hydrogels. Biomaterials, 25:21, pp. 5209-5215.
19. Shi, L., Plumley, CJ and Berkland, C. (2007) Biodegradable nanoparticle flocculates for dry powder aerosol formulation. Langmuir, 23:22, pp. 10897-10901.
20. Tang, Z., Tang, Y. and Fu, L. (2003) Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A. J Huazhong Univ Sci Technolog Med Sci, 23:2, pp. 166-168.
21. Wang, X., Wei, Y., Yuan, S., Liu, G., Lu, Y., Zhang, J. and Wang, W. (2005) Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer, 116:5, pp. 799-807.
22. Wang, Y., Li, Q., Feng, NP, Fan, ZZ, Nan, YL, Bao, BL, Sui, H., Rao, YM, Liu, NN and Li, XX (2007) Effects of tanshinone IIA nanoparticles on hepatoma and cyclin E expression in mice. Shanghai J Tradit Chin Med, 41:9, pp. 74-77.
23. Xiaohua, Liu, Wan Sia Heng, Paul, Li, Qi and Lai Wah, Chan (2006) Novel polymeric microspheres containing norcantharidin for chemoembolization. J Control Release, 116, pp. 35-41.
24. Yadav, AK, Mishra, P., Mishra, AK, Mishra, P., Jain, S. and Agrawal, GP (2007) Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine, 3:4, pp. 246-257.
25. Yuan, SL, Wei, YQ, Wang, XJ, Xiao, F., Li, SF and Zhang, J. (2004) Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol, 10, pp. 2024-2028.